Showing: 1 - 9 of 9 RESULTS

Global Disposable Tweezers Market to Surpass US$ 380.6 Million by 2027, Says Coherent Market Insights (CMI)

According to Coherent Market Insights, the global disposable tweezers market is estimated to be valued at US$ 276.0 million in 2020 and is expected to exhibit a CAGR of 5.30% over the forecast period (2020-2027).

Key Trends and Analysis of the Global Disposal Tweezers Market:

Global disposable tweezers market is expected to have significant growth, owing to increase in the surgical procedures and thus driving the growth of disposable tweezers market. According to US National Library of Medicine report published in 2016, stated that every year till 2016 approximately 310 million of individuals undergo surgical treatments due to various health conditions such as cancers, cardiovascular diseases, and oral diseases.

Moreover, global disposable tweezers market is going to witness significant growth owing to various research institutes and academic institutes are taking initiatives in field of disposables market. For instance, in 2017, UC San Diego Health, the academic health system of the University of California and academic hospital system in San Diego, suggested the pharmacy stores and retail stores in US to include following medical and surgical equipment first health kit. Medical and surgical equipment included in list were sterile gauge pads, rectangular bandages, pair of plastic tweezers and forceps and one breathing barrier.

Among region, Europe has increasing prevalence of oral diseases such periodontitis, and tooth decay are leading to rise in use of surgical equipment such as tweezers, dental glasses, these factors are expected to drive the disposable tweezers market in the region. According to World Health Organization report published in 2016, stated that approximately 20% to 90% of children of age below 6 years are suffering from dental caries and undergo procedures for removal of tooth decays and approximately 5% to 20% of adults are suffering from periodontitis.

Request Sample Copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/4228

Key Market Takeaways:

The global disposable tweezers market is expected to exhibit a CAGR of 5.30% over the forecast period, as increasing prevalence of dentistry procedures, increasing initiatives by research institutes for use of surgical equipment and increasing prevalence of surgical procedures.

Competitive Landscape:

Key players operating in the global disposable tweezers market include Burkle Inc, Sampling Systems Ltd, TIGA-MED Germany GmbH, MECO Instruments Pvt. Ltd, Arrowhead Forensics, 3M Healthcare, Cole-Parmer, Caplugs Evergreen, MilliporeSigma, and Changzhou Yuekang Medical Appliance Co., ltd.

Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/4228

Market Segmentation:

  • Global Disposable Tweezers Market, By Product Type :

  • Global Disposable Tweezers Market, By Application:

    • Dental

    • Surgical

    • Forensic

    • Others

  • Global Disposable Tweezers Market, By Distribution Channel:

    • Hospital Pharmacies

    • Retail Pharmacies

    • Online Pharmacies

  • Global Disposable Tweezers Market, By Region:

    • North America

    • Latin America

      • Brazil

      • Mexico

      • Argentina

      • Rest of Latin America

    • Europe

      • Germany

      • U.K.

      • France

      • Italy

      • Spain

      • Russia

      • Rest of Europe

    • Asia Pacific

      • China

      • India

      • Japan

      • Australia

      • South Korea

      • ASEAN

      • Rest of Asia Pacific

    • Middle East

      • GCC

      • Israel

      • Rest of Middle East

    • Africa

      • South Africa

      • Central Africa

      • North Africa

Related Market Intelligence Report:

Australia Reprocessed Medical Devices Market, By Device (Gastroenterology Devices, Cardiology Devices, Laparoscopy Devices, Orthopedic/ Arthroscopic Devices, ENT Devices, Others), By Classification (Critical,

Global Amitriptyline Market to Surpass US$ 762.6 Million by 2027, Says Coherent Market Insights (CMI)

According to Coherent Market Insights, the global amitriptyline market is estimated to be valued at US$ 527.4 million in 2020 and is expected to exhibit a CAGR of 5.3% during the forecast period (2020-2027).

Key Trends and Analysis of the Global Amitriptyline Market:

Various research institutes are studying the effect of amitriptyline for various disease indications, which is expected to drive the growth of global amitriptyline market. For instance, in April 2016, Boston Medical Center has initiated phase 2 clinical study to compare the effectiveness of amitriptyline versus placebo (inactive medication) in treating chronic laryngitis. The study is expected to complete in October 2022.

The increasing prevalence of depression or bipolar disorders is expected to drive demand for tricyclic antidepressants such as amitriptyline, and thereby contribute to the growth of the global amitriptyline market. According to the Global Burden of Disease Collaborative Network, in 2017, the prevalence of bipolar disorder ranged from 0.3% to 1.2% by country and around 46 million people suffered from the bipolar disorder worldwide. Bipolar disorder is a brain disorder, also known as manic illness that affects the mood, energy level, and other activities.

Moreover, the increasing prevalence of migraine is another factor contributing to growth of the amitriptyline market. According to Migraine Research Foundation, migraine is the third most common disease in the world, and has affected 39 million men, women and children in the U.S. and 1 billion worldwide in 2019.

Request Sample Copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/4226

Key Market Takeaways:

The Global Amitriptyline Market is expected to exhibit a CAGR of 5.3 % during the forecast period, due to increasing prevalence of neuropathic pain, and migraine.

Among regions, Asia Pacific is expected to witness significant growth in the global Amitriptyline Market during the forecast period owing to presence of local players in the region such as ALPIC BIOTECH (India), Dycine Pharmaceuticals Limited, Mesmer Pharmaceuticals, and other companies offering amitriptyline.

Competitive Landscape:

Key players operating in the Global Amitriptyline Market are Accord Healthcare Inc., Mylan Pharmaceuticals Inc., Sandoz Inc., Sun Pharmaceutical Industries Inc., Vintage Pharmaceuticals Inc., Zydus Pharmaceuticals USA Inc., Watson laboratories Inc., and Torrent Pharmaceuticals Ltd.

Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/4226

Market Segmentation:

Related Market Intelligence Report:

Collagen Filler Market, by Product Type (Collagen with PMMA and Collagen without PMMA), by Source (Bovine, Porcine, and Others), by Application (Face Rejuvenation, Wrinkles, Scar Treatment, Lip Treatment, Cellulite Reduction, and Others), By End User (Hospitals, Dermatology Clinics, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Size, Share, Outlook, and Opportunity Analysis, 2020 – 2027

Read more: https://www.coherentmarketinsights.com/market-insight/collagen-filler-market-4209

Softgel Tumble Dryer Market, by Instrument Type (Standard Tumble Dryer and Continuous Tumble Dryer), by End User (Pharmaceutical Companies, Health Supplements Companies, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Size, Share, Outlook, and Opportunity Analysis, 2020 – 2027

Read more: https://www.coherentmarketinsights.com/market-insight/softgel-tumble-dryer-market-4208

North America E-pharmacy Market, by Product Type (Prescription (Rx) and Over-the-counter) and by Country

Europe Telerehabilitation Systems Market to surpass US$ 104.6 million by 2027, Says Coherent Market Insights (CMI)

According to Coherent Market Insights, the Europe telerehabilitation systems market is estimated to be valued at US$ 56.8 million in 2020 and is expected to exhibit a CAGR of 9.1% during the forecast period (2020-2027).

Key Trends and Analysis of the Europe Telerehabilitation Systems Market:

The Europe telerehabilitation systems market is expected to witness significant growth owing to the increasing prevalence of stroke. According to the American Heart Association, in 2017, there were 1.12 million stroke incidents in the European Union, 9.53 million stroke survivors, 0.46 million deaths, and 7.06 million disability-adjusted life years were lost because of stroke.

Moreover, according to data published by the European Academy of Neurology (EAN), in 2017, around 220.7 million people in Europe were suffering from at least one neurological disease, and out of these, around 8.2 million people suffered a stroke.

Launch of telerehabilitation systems is also expected to drive the growth of the Europe telerehabilitation systems market. For instance, in 2014, CoRehab srl launched Riablo, a device designed to support physiotherapists in their everyday work with patients.

Request Sample Copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/4223

Key Market Takeaways:

The Europe telerehabilitation systems market is expected to exhibit a CAGR of 9.1 % during the forecast period (2020-2027) due to increasing clinical research conducted for rehabilitation of patients suffering cardiac diseases. For instance, in May 2018, American Heart of Poland conducted a trial on myocardial revascularization patients. The main reason of this trial was to study the efficacy of telemedicine in optimal cardiac rehabilitation program in 1,000 patients.

Germany is expected to be the most lucrative region in the telerehabilitation systems market due to presence of major players such as Doctor Kinetic and Virtualware Group. Moreover, developed healthcare infrastructure and various policies supporting telerehabilitation are also expected to aid in growth of the market in Germany.

Competitive Landscape:

Key players operating in the Europe telerehabilitation systems market are 270 Vision Ltd., CoRehab srl, SWORD Health, S.A., MIRA Rehab Limited, re.flex, Evolv Rehabilitation Technologies S.L., Brontes Processing Ltd., Bridgeway Senior Healthcare, Rehametrics, MindMaze , DIH Medical and Doctor Kinetic.

Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/4223

Market Segmentation:

  • Europe Telerehabilitation Systems Market, By Component:

  • Europe Telerehabilitation Systems Market, By Application:

    • Cardio-pulmonary

    • Neurology

    • Orthopedic

    • Others

  • Europe Telerehabilitation Systems Market, By End User:

    • Hospitals

    • Home Care Settings

    • Rehabilitation Centers

  • Europe Telerehabilitation Systems Market, By Country:

    • Germany

    • U.K.

    • France

    • Italy

    • Spain

    • Russia

    • Poland

    • Switzerland

    • Sweden

    • Belgium

    • Netherlands

    • Rest Of Europe

Related Market Intelligence Report:

Healthcare Mobility Solutions Market, By Type (Mobile Devices, Mobile Applications, Enterprise Mobility Platforms), By Application (Enterprise Solutions, mHealth Applications), By End User (Payers, Providers, Patients), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) – Size, Share, Outlook, and Opportunity Analysis, 2020 – 2027

Read more: https://www.coherentmarketinsights.com/market-insight/healthcare-mobility-solutions-market-4081

IT-enabled Healthcare Market, By Type (Software (Administrative Information Systems (AIS), Electronic Medical Record (EMR), Nursing Information Systems (NIS), Computer Assisted Diagnosis (CAD), Ancillary Information Systems), Services (Tele-Health, Healthcare Diagnostics, Remote Patient Monitoring, Healthcare Education, mHealth)), By End User (Public/Private healthcare

Global Phased Array Ultrasonic Transducer Market to Surpass US$ 729.1 Million by 2027, Says Coherent Market Insights (CMI)

According to Coherent Market Insights, the global phased array ultrasonic transducer market is estimated to be valued at US$ 525.6 million in 2020 and is expected to exhibit a CAGR of 4.80 % over the forecast period (2020-2027).

Key Trends and Analysis of the Global Phased Array Ultrasonic Transducer Market:

The global phased array ultrasonic transducer market is expected to show significant growth during the forecast period, owing to key companies focusing on product launches and product approvals to strengthen their position in the phase array ultrasonic transducer market. For instance, in 2017, Alpinion Medical Systems, one of South Korea’s global medical device manufacturers, launched E-CUBE 8, a smart, reliable medical device product with developed convex and phased array transducers of PowerView technology used for high performance with high quality medical imaging and multi-purpose utility in medical imaging.

Moreover, increasing incidence of heart disease conditions such as heart attack, coronary heart conditions, and hypertension are leading to rising cardiac examinations, which is expected to drive the phase array ultrasonic transducer market growth. For instance, according to the Centers for Disease Control and Prevention report, in 2017, around 2 in 10 deaths are caused due to coronary artery disease in adults less than 65 years old in the U.S. and approximately 1 in 5 people below the age of 65 suffer from silent heart attack.

Among region, North America is expected to register higher growth rate, owing to increasing innovations and development of advanced technology in phased array ultrasonic transducers. For instance, in 2019, Butterfly Network, a medical device company in the U.S., developed an ultrasonic transducer Butterfly IQ, which can be coupled with 10 approved android devices of Samsung and Google pixel. This innovation is changing the traditional way of medical imaging procedures, as Butterfly IQ is a portable ultrasonic medical device, which has enhanced compatibility with android phones, thus allowing greater accessibility for healthcare professionals.

Request Sample Copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/4212

Key Market Takeaways:

The global phased array ultrasonic transducer market is expected to exhibit a CAGR of 4.80 % over the forecast period, owing to increasing product launches, product approvals, and rising innovation in development of advanced technology in phased array ultrasonic transducer medical imaging procedures

Competitive Landscape:

Key players operating in the global phase array ultrasonic transducer market include B K Medical Systems Inc, Koninklijke Philips N.V., GE Healthcare, Spacelabs Healthcare, SonoScape Medical Corp, Edan Instruments Inc, Samsung Healthcare, Mindray Medical International Limited, Esaote, FUJIFILM Medical Systems, Siemens Healthineers AG, Canon Medical Systems Corporation, and Butterfly Network Inc.

Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/4212

Market Segmentation:

  • Global Phased Array Ultrasonic Transducers, By Type:

    • Linear Array

    • Annular Array

    • Circular Array

  • Global Phased Array Ultrasonic Transducers, By Application:

    • Cardiovascular

    • Neurological

    • Renal

    • Gynecology

    • Others

  • Global Phased Array Ultrasonic Transducers, By End User:

  • Global Phased Array Ultrasonic Transducers, By Region:

    • North America

    • Latin America

      • Brazil

      • Mexico

      • Argentina

      • Rest of Latin America

    • Europe

      • Germany

      • U.K.

      • France

      • Italy

      • Spain

      • Russia

      • Rest of Europe

    • Asia Pacific

      • China

      • India

      • Japan

      • Australia

Global Collagen Filler Market to surpass US$ 648.1 Million by 2027, Says Coherent Market Insights (CMI)

According to Coherent Market Insights, the global collagen filler market is estimated to be valued at US$ 648.1 million in 2020 and is expected to exhibit a CAGR of 7.4 % during the forecast period (2020-2027).

Key Trends and Analysis of the Global Collagen Filler Market:

Key companies are focusing on research and development activity and technological advancement in collagen filler is expected to drive the global collagen filler market growth. For instance, in September 2020, CollPlant, an aesthetic medicine company, presented the overview of a plant-derived recombinant human collagen for anti-ageing therapies at the Science of Aging Virtual Symposium 2020 which is a symposium event for showcasing innovation in the field of aesthetic medicine.

Moreover, increasing cosmetic procedures such as face lifts, wrinkle removal, breast augmentation, and lip treatments are expected to drive the global collagen filler market growth. For instance, according to American Society of Plastic Surgeons Report 2020, in 2019, 123,685 face lift procedures and around 37% of soft filler injection were used for treatment of various skin conditions such as skin ageing, wrinkles and face lift procedures across the globe.

Furthermore, various initiatives have been taken by regulating bodies to ensure efficient use to synthetic and cosmetics products for safer use of dermal fillers and to avoid side effects. For instance, in 2018, the US Food Drug and Administration approved temporary/absorbable dermal fillers for correction of moderate to severe face wrinkles, skin folds and unapproved dermal fillers for breast augmentation, size of buttocks, enhance fullness of feet and dermal implants into the bone, tendon, ligament and muscle.

Among regions, the North America market is expected to register highest market share owing to an increase in plastic surgery procedures such as face rejuvenations, lip treatments and temporary procedures such as face line corrections. According to the American Society of Plastic Surgeons report of May 2020, 1.8 million plastic surgeries were performed by certified plastic surgeons in 2018.

Request Sample Copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/4209

Key Market Takeaways:

The global collagen filler market is expected to exhibit a CAGR of 7.4% during the forecast period owing to increasing on research and development along with technological advancement in collagen fillers along with increasing number of cosmetic procedures such as face lifts, wrinkle removal, face rejuvenation and lip treatments.

Competitive Landscape:

Key players operating in the global collagen filler market are Allergan, Inc., Johnson & Johnson, Collplant Holdings Ltd, Ortho Dermatologics, Inc., Suneva Medical, Inc., Merz Pharma GmbH & Co. KGaA, Surgical Specialties Corporation, Sinclair Pharma, Inamed GmbH, and Endo International plc.

Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/4209

Market Segmentation:

Related Market Intelligence Report:

Ischemia Reperfusion Injury Therapeutics Market, by Indication (Heart Injury, Kidney Injury, Intestine Injury, and Other Injury), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Size, Share, Outlook, and Opportunity Analysis, 2020 – 2027

Read more: https://www.coherentmarketinsights.com/market-insight/ischemia-reperfusion-injury-therapeutics-market-4105

About Us:

Coherent Market Insights is a global market intelligence and

Europe Animal Healthcare Market to Surpass US$ 17,837.8 Million by 2027, Says Coherent Market Insights (CMI)

According to Coherent Market Insights, the Europe animal healthcare market is estimated to be valued at US$ 13,119.7 million in 2020 and is expected to exhibit a CAGR of 4.5% over the forecast period (2020-2027).

Key Trends and Analysis of the Europe Animal Healthcare Market:

Key trends in the market are rising incidence of zoonotic viral pathogens, increasing demand for protein from animal sources, and government initiatives to provide improved animal healthcare.

Market players are focused on launches and approvals of products for better offerings in the market. For instance, in August 2017, Boehringer Ingelheim launched Centragard, a transdermal solution for the treatment and control of three most common intestinal parasites in cats such as hookworms, roundworms, and tapeworms.

Increasing adoption of various growth strategies by market players such as investments in order to maintain a competitive edge in the market is expected to drive the market growth. For instance, in July 2018, Boehringer Ingelheim announced investment of around US$ 221 million for establishing a production center to cater to the increasing demand for drugs of foot-and-mouth disease and Bluetongue virus.

The most common zoonotic viral diseases diagnosed in Europe over the past few years include rabies, influenza virus, Rift Valley fever, dengue fever, West Nile fever, crimean-congo hemorrhagic fever, and others. According to the HealthforAnimals Association, around 60% of diseases in the world are zoonotic, which are responsible for 2.4 billion cases of human illnesses and 2.2 million deaths, annually.

Furthermore, companies and the subsidiaries operating in the Europe intend to leverage their proprietary technologies for the development of novel therapeutics to treat serious medical conditions in pets. For instance, in 2017, OPKO Health Spain evaluated Enko 1 for use in companion animals. Enko 1 is a patented intra-articular injectable hyaluronic acid and chondroitin sulfate complex to relieve pain.

Request Sample Copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/550

However, stringent regulations on sales and usage of antibiotics, and high cost of animal healthcare services are major factors hindering the market growth. Antimicrobial resistance (AMR) is a major concern limiting the usage of antibiotics, which has resulted in lesser use of antibiotics. In 2015, the Europe government published guidelines regarding the proper use of antimicrobial agents in veterinary medicine to control AMR in animals, which has led to various restrictions.

Key Market Takeaways:

The Europe animal healthcare market is expected to exhibit a CAGR of 4.5% over the forecast period, owing to rising incidence of zoonotic viral pathogens, increasing demand for protein from animal sources, increasing government initiatives to provide improved animal healthcare, and adoption of inorganic growth strategies such as acquisitions and collaborations by market players. For instance, in February 2019, UNION Therapeutics A/S and Ceva Santé Animale S.A. partnered for the development of UNI836 for treating canine pyoderma in companion animals.

Key players in the market are focused on product approvals and launches to enhance their product portfolio, which in turn is expected to propel the market growth over the forecast period. For instance, in September 2015,

Global Anti-aging Treatment Market to Surpass US$ 34.49 Billion by 2027, Says Coherent Market Insights (CMI)

According to Coherent Market Insights, the global anti-aging treatment market is estimated to be valued at US$ 21.06 billion in 2020 and is expected to exhibit a CAGR of 7.3% over the forecast period (2020-2027).

Key Trends and Analysis of the Global Anti-aging Treatment Market:

Key trends in the market include increasing launches of anti-aging treatment products, increasing number of aesthetic procedures, and increasing acquisitions, partnerships, and agreements by key players. These are expected to aid in growth of the market.

According to the 2018 Plastic Surgery Statistics Report by the American Society of Plastic Surgeons, approximately 17.7 million cosmetic procedures were performed in the U.S. in 2018. According to the same source, the top three minimally invasive cosmetic procedures include botulinum toxin type A, soft tissue fillers, and chemical peel.

Moreover, key players are focusing on raising finances through investments by private equity platform in order to enhance their market presence, which is expected to drive growth of the anti-aging treatment market over the forecast period. For instance, in May 2018, Rodan + Fields, LLC, a U.S.-based skincare brand, announced that TPG Capital, an American investment company, invested in Rodan + Fields, LLC. The investment through TPG Capital will provide Rodan + Fields, LLC with an access to better business building expertise in order to expand its business domestically and internationally.

Furthermore, increasing product launches by key players is expected to propel the market growth over the forecast period. For instance, in January 2019, T.A. Sciences, a provider of clinically tested wellness products, launched T.A.-65, an anti-oxidant formula, developed for reducing the visible signs of aging, evening out discolored and blotchy skin tones, increasing skin firmness and tone, and diminishing facial wrinkles and folds.

Request Sample Copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/4210

Key Market Takeaways:

The global anti-aging treatment market is expected to exhibit a CAGR of 7.3% over the forecast period. This is owing to increasing number of aesthetic procedures. According to the International Society of Aesthetic Plastic Surgery, around 227,089 facial rejuvenation procedures were performed in Japan in 2017.

Among regions, North America is expected to hold dominant position in the global market over the forecast period, owing to high presence of key players such as NuFACE and Alma Laser, and rising number of minimally invasive cosmetic procedures. According to the International Society of Aesthetic Plastic Surgery, around 1,903,660 non-surgical procedures including botulinum toxin, were performed in the U.S. in 2017.

Key players operating in the global anti-aging treatment market include Allergan Plc, Estée Lauder Companies, Shiseido Company, Beiersdorf AG, L’Oréal S.A, NuFACE, Ostium Cosmetics, PhotoMedex, Inc, Alma Laser, Rodan & Fields, LLC, and others

Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/4210

Market Segmentation:

  • Global Anti-aging Treatment Market, By Product Type:

  • Global Anti-aging Treatment Market, By Technology:

  • Global Anti-aging Treatment Market, By End User:

    • Hospitals

    • Skin Care Clinics

    • Homecare Settings

    • Others

  • Global Anti-aging Treatment Market, By Region:

    • North America

    • Latin America

      • Brazil

      • Mexico

      • Argentina

      • Rest of Latin America

    • Europe

      • Germany

      • U.K.

      • France

      • Italy

      • Spain

      • Russia

      • Rest

Global Brain Health Supplements Market to Surpass US$ 13,492.6 Million by 2027, Says Coherent Market Insights (CMI)

According to Coherent Market Insights, the global brain health supplements market is estimated to be valued at US$ 7,038.0 million in 2020 and is expected to exhibit a CAGR of 8.5% during the forecast period (2020-2027).

Key Trends and Analysis:

Key trends in the market include rising incidence of depression, anxiety and stress levels, increasing health awareness, and product launches.

Rising incidence of Alzheimer, depression, anxiety, stress, and other mental health conditions is expected to contribute to the growth of the brain health supplements market. For instance, according to data published by Alzheimer’s Association in 2017, around 5.5 million people in the U.S. of all ages were suffering from Alzheimer’s dementia.

Moreover, key players operating in the market are focused on product launches in order to expand their offerings. For instance, in June 2020, Elysium Health, in partnership with University of Oxford, U.K., announced the launch of Matter – a brain health supplement which is based on the Oxford’s VITACOG study which contains vitamin B, omega 3 lysine complex and bilberry extract for cognitive health and memory loss treatment.

Market players are investing in validating efficiency of novel products in the market. Moreover, market players are committed to offering new and improved products to address the critical unmet need for brain health supplements. For instance, in May 2020, a study conducted by researchers from Central Queensland University in collaboration with the Deakin University in Australia and Nanyang Technological University in Singapore showed positive results for USANA CopaPrime, a product of USANA Health Sciences, Inc.

Request Sample Copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/4205

Key Market Takeaways:

The global brain health supplements market is expected to exhibit a CAGR of 8.5% during the forecast period, owing to increasing product launches. For instance, in April 2015, Cerebral Success, a brain-health company announced the launch of SmartX, a combination of Cognizin Citicoline with other brain health supplements to enhance and improve mental energy and focus. The company has made its products available through distribution channels such as GNC stores, Amazon.com and eSupplements.com, luckyvitamin.com.

North America is expected to hold a dominant position in the global brain health supplements market during the forecast period owing to increasing health awareness, high expenditure on supplements and adoption of inorganic growth strategies by market players. For instance, in January 2015, Synergy Strips Corp announced the acquisition of FOCUSfactor a brain health supplement brand, an asset from the Factor Nutrition Labs, LLC. The FOCUSfactor is sold at retail stores such as Costco, Sam’s Club, Walmart, Walgreens, CVS and The Vitamin Shoppe.

Competitive Landscape:

Key players operating in the global brain health supplements market are AlternaScript, LLC, Accelerated Intelligence Inc., Liquid Health, Inc., HVMN Inc., Natural Factors Nutritional Products Ltd., KeyView Labs, Inc., Onnit Labs, LLC, Purelife Bioscience Co., Ltd., Quincy Bioscience, Cerebral Success, Amway, Puori, Ocean Health, and Schiff.

Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/4205

Market Segmentation:

  • Global Brain Health Supplements Market, By Product Type:

    • Herbal Extracts

      • Ginseng

      • Ginkgo Biloba

      • Curcumin

      • Lions Mane

      • Others

    • Vitamins & Minerals

Global Antifungal Drugs Market to Surpass US$ 13,132.8 Mn by 2027, Says Coherent Market Insights (CMI)

According to Coherent Market Insights, the global antifungal drugs market is estimated to be valued at US$ 11,591.0 Mn in 2020 and is expected to exhibit a CAGR of 1.8% during the forecast period (2020-2027).

Key Trends and Analysis of the Global Antifungal Drugs Market:

The increasing incidence of invasive candidiasis and vaginal candidiasis is expected to propel the global antifungal drugs market growth. The rising prevalence of invasive candidiasis, vaginal candidiasis, and preterm births poses high economic burden on the patient-population. For instance, according to the Centers for Disease Control and Prevention (CDC), candidemia, a form of invasive candidiasis, was one of the most common bloodstream infections in the U.S., with an average incidence of around 9 per 100,000 cases between 2013 and 2017.

Moreover, according to the same source, in 2017, around 84% of the total healthcare cost and 48% of the hospitalizations for candida infections was attributable to invasive candidiasis. The average cost per hospitalization for invasive candidiasis was around US$ 64,723 to US$ 153,090.

The increasing number of preterm births is expected to boost the market growth. For instance, according to the Kolling Institute of Medical Research published its result in 2015, that shows vaginal candidiasis can increase the risk of preterm births.

Moreover, according to a survey by researchers from the University of Miyazaki in 2017, the incidence of vulvovaginal candidiasis (VC) during pregnancy is 13 to 20% globally.

Furthermore, according to the Obstetric and Gynecology Department, Italy, 2018, VC is estimated to be the second most common cause of vaginitis and is found in 40% of women with vaginal discomfort. VC can cause systemic infections in premature neonates, particularly those with low birth weight.

Request Sample Copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/237

Key Market Takeaways:

The global antifungal drugs market is expected to exhibit a CAGR of 1.8% during the forecast period (2020-2027), owing to the increasing incidence of invasive candidiasis and vaginal candidiasis.

The growth of the North America antifungal drugs market is attributed to launches of antifungal drugs in the U.S.

Competitive Landscape:

Key players operating in the global antifungal drugs market are GlaxoSmithKline Plc, Bayer AG, Abbott Laboratories, Merck & Co., Inc, Glenmark Pharmaceuticals Limited, Enzon Pharmaceuticals, Inc., Pfizer Inc., Gilead Sciences, Inc., Sanofi S.A. and Astellas Pharma, Inc.

Buy-Now this Research report @ https://www.coherentmarketinsights.com/insight/buy-now/237

 

Market Segmentation:

  • Global Antifungal Drugs Market, By Dosage Form:

    • Powders

    • Ointments

    • Drugs

    • Others

  • Global Antifungal Drugs Market, By Region:

    • North America

    • Europe

      • U.K.

      • Germany

      • Italy

      • Spain

      • France

      • Russia

      • Rest of Europe

    • Asia Pacific

      • Australia

      • India

      • China

      • Japan

      • ASEAN

      • South Korea

      • Rest of Asia Pacific

    • Latin America

      • Brazil

      • Mexico

      • Argentina

      • Rest of Latin America

    • Middle East

      • GCC

      • Israel

      • Rest of Middle East

    • Africa

      • South Africa

      • Central Africa

      • North Africa

Related Market Intelligence Report:

Brain Health Supplements Market, by Product Type (Herbal Extracts {Ginseng, Ginkgo Biloba, Curcumin, Lions Mane, and Others}, Vitamins & Minerals {Vitamin B, Vitamin C &  E, and Others}, and Natural Molecules {Acetyl-L-Carnitine, Alpha GPC, Citicoline, Docosahexaenoic Acid, and Others}), by Application (Memory